TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Emcure Pharmaceuticals Ltd.

EMCURE on NSE · 19 Nov 2026

NIFTY 500

2,344.70 ▲ +0.42 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Balance sheet

What the company owns and owes, as reported.

₹ cr30 Sep 202631 Mar 202630 Sep 202531 Mar 202530 Sep 2024
Total assets10,1649,6129,3938,2338,124
Equity attributable to owners5,3444,9504,7434,4464,118
Current borrowings9309521,025542658
Non-current borrowings537252319190284
Cash and cash equivalents137137472156162

Cash flow

Where the cash came from and went, by financial year.

₹ crYear to Mar 2026Year to Mar 2025
Cash flow from operating activities944852
Cash flow from investing activities-1,193-94
Cash flow from financing activities343-814
Purchase of property, plant and equipment361222

Figures are consolidated, in ₹ cr unless the line is a percentage, from the company's results filed with NSE. Companies report a balance sheet twice a year and cash flow for the year to date; a dash means the line was not reported.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in